Physician profile
Robert Thomas Lyon
NPI 1225097322
$2,813.86
in general payments reported to CMS, 2019-2025
11 companies · $358 in 2025
The $358 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $240 · 2021: $366 · 2022: $412 · 2023: $373 · 2024: $433 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,002.62 | 2019-2025 | Exparel, Iovera, Zilretta |
| Medtronic, INC. | $582.21 | 2022-2024 | Mcgrath Mac, Nellcor, Bis |
| Merck Sharp & Dohme LLC | $371.39 | 2019-2020 | |
| Csl Behring | $222.77 | 2019-2023 | Kcentra |
| Chiesi USA, INC. | $129.41 | 2019 | |
| Acacia Pharma INC | $119.82 | 2021 | |
| Grifols USA, LLC | $117.30 | 2019 | |
| Eagle Pharmaceuticals, INC. | $115.07 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $84.03 | 2025 | |
| Avanos Medical | $37.54 | 2025 | On-Q Pump and Accessories |
| Halozyme INC | $31.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lyon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.